Quantcast

Latest Rhinitis Stories

2009-11-20 03:00:00

OXFORD, England, November 20 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development.

2009-11-10 11:18:00

MADISON, Wis., Nov. 10 /PRNewswire/ -- In response to the study, "Long-term use of nasal saline irrigation: Harmful or helpful?", presented at the American College of Allergy, Asthma & Immunology Annual Meeting on November 8th, Diane G.

2009-11-02 07:38:00

KENILWORTH, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S.

2009-10-16 08:14:43

Injecting botulinum toxin (botox) to treat intrinsic or allergic rhinitis may be a thing of the past as researchers have now shown that sponges soaked in botox are equally effective in treating the condition.

2009-10-15 14:00:00

Million EUR 2008 2009 09/08 EURm % Sales EURm % Sales Var.% Southern Europe (1) 23.8 70 26 68 9 Other EU countries (2) 8.6 25 10.3 27 20 Other markets 1.8 5 1.9 5 8 SLIT 26.3 77 30.5 79 16 SCIT 6.5 19...

2009-10-05 13:54:17

A comparison of symptoms in patients with allergic rhinitis (AR) and non-allergic rhinitis (NAR) revealed that those with the NAR experienced worse symptoms.

2009-10-05 06:10:00

Patients who suffer from both allergic rhinitis and obstructive sleep apnea (OSA) may experience escalated symptoms of stress and fatigue.

2009-10-02 06:17:00

WASHINGTON, Oct. 2 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) announced today the 2009 Fall Allergy Capitals(TM) rankings. The annual research project ranks the fall's 100 most challenging cities for people with fall allergies.

2009-09-16 12:14:00

ANTONY, France, September 16 /PRNewswire-FirstCall/ -- Stallergenes S.A. has announced the first results of a new phase IIb/III clinical trial (VO59.08) conducted in allergic rhinitis caused by birch pollen and concerning the development of a sublingual immunotherapy tablet containing the recombinant allergen of this pollen, rBet v 1. This study is the first ever to use a recombinant allergen as an active substance.

b8a4b4d624296d8a7648b35e275df88f1
2009-09-15 12:56:18

Swimming in a chlorinated pool may increase a child’s chances of experiencing problems with asthma and allergies.


Word of the Day
marcescent
  • Withering but not falling off, as a blossom that persists on a twig after flowering.
The word 'marcescent' comes from a Latin word meaning 'to wither'.
Related